Royal Bank Of Canada Mesoblast LTD Transaction History

Royal Bank Of Canada

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.0 - $1.39 $69 - $95	69 Added 56.1%	192 $0
Q3 2023 Nov 14, 2023	SELL	$1.22 - $4.83 $9,191 - $36,389	-7,534 Reduced 98.39%	123 $0
Q4 2022 Feb 14, 2023	BUY	$2.73 - $3.7 $20,510 - $27,798	7,513 Added 5217.36%	7,657 $22,000
Q3 2022 Nov 14, 2022	BUY	$0.48 - $3.48 $54 - $393	113 Added 364.52%	144 $0
Q1 2022 May 16, 2022	SELL	$3.58 - $4.98 $68 - $94	-19 Reduced 38.0%	31 $0
Q4 2021 Feb 14, 2022	BUY	$4.17 - $7.09 $191 - $326	46 Added 1150.0%	50 $0
Q3 2021 Nov 15, 2021	SELL	$5.87 - $7.85 $481 - $643	-82 Reduced 95.35%	4 $0
Q2 2021 Aug 16, 2021	BUY	$6.69 - $9.0 $575 - $774	86 New	86 $1,000

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $2.51B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.